Relmada Therapeutics
Price & Volume
Stats
See moreOpen | $0.58 |
Previous Close | $0.58 |
Day Range | $0.58-$0.58 |
52W Range | $0.24-$3.98 |
Market Cap | $18.6M |
Shares Short | 401,305 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.20 |
News
See moreYahoo Finance • 5 days ago
Relmada outlines 2026 trial launches for NDV-01 and sepranolone as pipeline advances
Yahoo Finance • 13 days ago
Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Yahoo Finance • last month
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
Yahoo Finance • 2 years ago
Positive Signs As Multiple Insiders Buy Relmada Therapeutics Stock
About
CEO | Dr. Sergio Traversa M.B.A., Pharm.D. |
Address | 2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |
